Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.
This article aimed to articulate the most important unmet scientific needs in rheumatology. At the 25th Advances in Targeted Therapies (ATT) meeting, over 100 investigators joined 6 disease-focused breakout groups (rheumatoid arthritis [RA], psoriatic arthritis [PsA], axial spon…